Clinical trials are an essential step in getting the most promising new therapies available to those who need them most. A Clinical Research Facility is where this important work happens, with some of these spaces designed to host early-phase trials—when treatments are first made available to a small, select group.
These clinical trials have enormous value for participants, clinicians and the scientific community. But until now, there hasn’t been anywhere in East London suitable for early-phase clinical trials. This has made it harder for patients to gain potential benefit from new drugs, has limited options for clinicians and for locally-led research.
But this is about to change.
We’re partnering with Barts Health NHS Trust and Queen Mary University of London to build a new, early phase Clinical Research Facility at The Royal London Hospital in Whitechapel. And our generous donors are helping to make it happen. This new facility will enable more life-changing research for people like Suresh. And our generous donors are helping to make it happen.
“I can say, without any doubt, that my clinical trial gave me my life back. And soon, with a new Clinical Research Facility, we could transform the lives of so many more people in East London and beyond. I’d urge anyone who is able to help support this important appeal to please do so.”Suresh, clinial trial patient and Barts Charity Supporter
Clinial trial patient and Barts Charity Supporter, Suresh
We still know too little about how effective particular drugs may be in patients from different ethnic backgrounds. This problem can be compounded when clinical trials for new treatments don’t adequately reflect the make-up of the likely patient population. But by conducting more early phase trials in East London—and by ensuring that eligible patients from all of our many communities can participate—we will be helping to ensure better outcomes: for our patients, for London, and for the world.
The project recently received the endorsement of a £1 million National Institute of Health and Care Research (NIHR) Clinical Research Facility infrastructure award, allowing us to join the national NIHR CRF network.
"By building a state-of-the-art Clinical Research Facility at The Royal London Hospital, more of our diverse local population will be able to take part in drug trials, helping us to make sure these new drugs are safe and effective for everyone.”Professor Rupert Pearse, Professor of Intensive Care Medicine at Queen Mary University of London
We still know too little about how effective particular drugs may be in patients from different ethnic backgrounds. This problem can be compounded when clinical trials for new treatments don’t adequately reflect the make-up of the likely patient population. But by conducting more early phase trials in East London—and by ensuring that eligible patients from all of our many communities can participate—we will be helping to ensure better outcomes: for our patients, for London, and for the world.
The project received the endorsement of a £1 million National Institute of Health and Care Research (NIHR) Clinical Research Facility infrastructure award, allowing us to join the national NIHR CRF network.
The Clinical Research Facility will allow more early phase clinical trials to take place in East London, bringing potentially life-changing treatments to our local population and shaping the future of healthcare through truly world-class innovations.
Suresh received life-changing treatment for rheumatoid arthritis through a clinical trial at Whipps Cross Hospital. Here’s what your support of clinical trials can do for the East London community.
The Charles Wolfson Charitable Trust's pledge will support the development of a new Clinical Research Facility at The Royal London Hospital. This could mean earlier access to life-changing treatments for people in East London.
